Imagine using sunlight like a tiny factory worker — instead of burning fuel, light triggers chemical reactions inside miniature channels thinner than a hair. PHOTOTRAIN trained 14 young researchers to build these micro-scale photoreactors that can split water into hydrogen fuel or produce pharmaceutical ingredients without harsh industrial conditions. Think of it as replacing the brute-force heat and pressure of traditional chemistry with a precise beam of light flowing through a chip-sized reactor. The team demonstrated working prototypes for water splitting — a key step toward clean hydrogen production.
Chemical and pharmaceutical manufacturers still rely heavily on energy-intensive, high-temperature, high-pressure batch processes that generate significant waste. Meanwhile, hydrogen producers face high electricity costs for water electrolysis. There is a growing demand for cleaner, more efficient ways to drive chemical reactions — and sunlight is the most abundant energy source that remains largely untapped in industrial chemistry.
The project built and demonstrated 2 key prototypes: a Z-scheme microfluidic photoreactor for water splitting and half-reaction water splitting photoreactors. Across 25 total deliverables, the team developed light-triggered chemical processes using self-organized photoactive interfaces in microfluidic channels, targeting both solar fuel production and stereoselective pharmaceutical synthesis.
If you are a hydrogen technology company struggling with the energy cost of electrolysis — this project developed Z-scheme microfluidic photoreactors for water splitting that use light instead of electricity. The demonstrated prototypes could offer a complementary pathway to produce hydrogen from sunlight and water, potentially reducing your dependence on grid power for hydrogen generation.
If you are a pharmaceutical manufacturer dealing with expensive multi-step synthesis requiring harsh conditions — this project developed light-triggered stereoselective organocatalytic processes in microfluidic systems. These could replace energy-intensive batch reactors with continuous-flow photoreactors, improving selectivity while reducing waste and energy consumption in producing chiral drug intermediates.
If you are a process equipment company looking to expand your product line into photocatalytic applications — this project produced 25 deliverables including demonstrated microfluidic photoreactor designs for both water splitting and organic synthesis. Licensing or co-developing these reactor designs could give you a first-mover advantage in the growing market for light-driven continuous manufacturing.
The project data does not include specific cost figures for the microfluidic photoreactors. Based on available project data, the technology is still at the prototype stage, so costs would depend heavily on scale-up engineering and material choices. Engaging the consortium partners directly would be needed for realistic cost projections.
The project demonstrated microfluidic photoreactors — inherently small-scale devices. Scaling typically involves numbering-up (running many micro-channels in parallel) rather than making bigger reactors. The consortium included 5 industry partners across 6 countries, suggesting some industrial input on scalability, but full industrial-scale deployment was not demonstrated within this project.
PHOTOTRAIN was a training network (MSCA-ITN-ETN) coordinated by the University of Bologna with 14 partners. IP generated during the project would be governed by the consortium agreement between these partners. Contact the coordinator to discuss licensing terms for specific photoreactor designs or catalytic processes.
The project produced 2 demonstrated photoreactor prototypes — a Z-scheme microfluidic photoreactor for water splitting and half-reaction water splitting photoreactors. These are working lab prototypes, not commercial products. Significant engineering work remains to move from proof-of-concept to a deployable system.
Based on available project data, no specific regulatory compliance testing (REACH, GMP) was reported. Photocatalytic processes generally use milder conditions than traditional chemistry, which may simplify regulatory approval, but any commercial deployment would require standard regulatory assessment.
The microfluidic photoreactor approach is designed as a modular add-on rather than a replacement for entire production lines. The project specifically explored how light-triggered processes could reform current industrial transformations. Integration feasibility would depend on your specific process and throughput requirements.
PHOTOTRAIN ended in September 2020. The 14 trained researchers are now distributed across academia and industry in 6 countries. The University of Bologna and consortium partners may have continued this work in follow-up projects. Check the project website for updates on successor initiatives.
The PHOTOTRAIN consortium brings together 14 partners from 6 countries (Belgium, Spain, France, Israel, Italy, UK), with a healthy 36% industry ratio — 5 industry partners including 2 SMEs alongside 5 universities and 3 research organizations. This mix signals genuine interest from the private sector in photocatalytic technology, not just an academic exercise. The coordinator, University of Bologna, is a top-tier European research institution. The presence of industry partners from multiple countries suggests the technology has cross-border commercial appeal, particularly in the chemical and energy sectors. However, as a training network, the consortium was optimized for education rather than product development, so commercialization would likely require a new partnership structure.
Coordinator is at University of Bologna (Italy). Use Google AI search to find the principal investigator's contact details for licensing discussions.
Want to explore how photocatalytic microreactors could fit your production process? SciTransfer can connect you with the right research team and help evaluate technical fit — contact us for a tailored briefing.
